82 related articles for article (PubMed ID: 28725677)
21. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
22. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand.
Termrungruanglert W; Khemapech N; Tantitamit T; Sangrajrang S; Havanond P; Laowahutanont P
Gynecol Oncol Rep; 2017 Nov; 22():58-63. PubMed ID: 29034308
[TBL] [Abstract][Full Text] [Related]
25. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
27. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Colposcopic Biopsy Results of Patients Who have Cytomorphological Normal but HPV 16-18 or Other High-Risk HPV Subtypes Positive.
Aydoğmuş H; Aydoğmuş S
Asian Pac J Cancer Prev; 2019 Feb; 20(2):417-420. PubMed ID: 30803201
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence and genotype distribution of human papillomavirus in patients attending to gynecology polyclinics].
Kaleli İ; Aksoy L; Demir M; Mete E; Önder SZ; Bir F; Kaleli B
Mikrobiyol Bul; 2019 Apr; 53(2):170-178. PubMed ID: 31130121
[TBL] [Abstract][Full Text] [Related]
30. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.
Cambou MC; Luz PM; Lake JE; Levi JE; Coutinho JR; de Andrade A; Heinke T; Derrico M; Veloso VG; Friedman RK; Grinsztejn B
AIDS Patient Care STDS; 2015 Jan; 29(1):4-12. PubMed ID: 25361401
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of human papilloma virus and their high-risk genotypes in Sri Lankan women.
Shanaka KASN; Wilathgamuwa S; Gunawardene YINS; Dassanayake RS
Virusdisease; 2018 Mar; 29(1):27-31. PubMed ID: 29607355
[TBL] [Abstract][Full Text] [Related]
32. Prevalence Oncogenic Human Papillomavirus in Cervical Cancer Patients in Riau Province Indonesia.
Savira M; Suhaimi D; Putra AE; Yusrawati Y; Lipoeto NI
Rep Biochem Mol Biol; 2022 Jan; 10(4):573-579. PubMed ID: 35291605
[TBL] [Abstract][Full Text] [Related]
33. Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia.
Robles C; Monfil L; Ibáñez R; Roura E; Font R; Peremiquel-Trillas P; Brotons M; Martínez-Bueno C; de Sanjosé S; Espinàs JA; Bruni L
Front Oncol; 2024; 14():1338859. PubMed ID: 38873256
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer in Thailand: 2023 update.
Wongpratate M; Bumrungthai S
Obstet Gynecol Sci; 2024 May; 67(3):261-269. PubMed ID: 38528826
[TBL] [Abstract][Full Text] [Related]
35. Letter to the editor: "A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand".
Vásquez-Medina MJ; Villegas-Otiniano PJ; Benites-Zapata VA
Gynecol Oncol Rep; 2018 Feb; 23():45-46. PubMed ID: 29892688
[No Abstract] [Full Text] [Related]
36. Cancer cytology program as a community effort.
Ragula BD; Marks R
Can Fam Physician; 1971 Jan; 17(1):87-94. PubMed ID: 20468611
[No Abstract] [Full Text] [Related]
37. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
38. Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
Kositamongkol C; Kanchanasurakit S; Mepramoon E; Talungchit P; Chaopotong P; Kengkla K; Chaisathaphol T; Saokaew S; Phisalprapa P
BMC Public Health; 2023 Dec; 23(1):2413. PubMed ID: 38049773
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of high-risk human papillomavirus genotypes and related risk factors among Iranian women.
Hashemnejad M; Mirmajidi R; Rahimzadeh M; Ataei M
J Med Life; 2022 Nov; 15(11):1340-1346. PubMed ID: 36567834
[TBL] [Abstract][Full Text] [Related]
40. Could HPV Type 33 Be More Risky Than We Thought?
Purut YE; Uçkan K
Int J Surg Pathol; 2023 Feb; 31(1):4-10. PubMed ID: 36471500
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
